|
Hot Stocks
|
In an interview on… In an interview on CNBC's Mad Money, Bob Martin said, "We've been hearing from customers who may never have considered RVs before." The company is seeing the same amount of demand in Europe as in the U.S., Martin noted. About 90% of the company's labor force came back after the pandemic, according to Martin. ShowHide Related Items >><< - $111.17 /
+11.18 (+11.18%) - 06/08/20
- Thor Industries provides update amid COVID-19 pandemic
- 06/08/20
- Thor Industries says North America market indicators are increasingly positive
- 05/29/20
- Thor Industries announces operational update with start of RV travel season
- 05/26/20
- Recreational vehicle stocks spike amid safe travel concerns, outdoor season
- $111.17 /
+11.18 (+11.18%) - 06/01/20 Monness Crespi
- Camping World price target raised to $24 from $18 at Monness Crespi
- 04/17/20 Wolfe Research
- Thor Industries initiated with an Outperform at Wolfe Research
- 04/14/20 KeyBanc
- Thor Industries price target lowered to $62 from $69 at KeyBanc
- 04/08/20 Northcoast
- Thor Industries, Camping World downgraded at Northcoast after RV industry checks
- $111.17 /
+11.18 (+11.18%) - 06/08/20
- Thor Industries reports Q3 EPS 43c, consensus (26c)
- 03/09/20
- Thor Industries reports Q2 EPS 52c, consensus 70c
- 12/09/19
- Thor Industries reports Q1 EPS 92c, consensus $1.23
- $111.17 /
+11.18 (+11.18%) - 06/08/20
- Fly Intel: Pre-market Movers
- 03/23/20
- Fly Intel: After-Hours Movers
- 12/09/19
- Fly Intel: Wall Street's top stories for Monday
- 12/09/19
- Fly Intel: Wall Street's top stories at midday
|
|
On The Fly
|
Check out this morning's… ShowHide Related Items >><< - 06/08/20
- Ebix considers countersuit against Yatra following merger deal termination
- 06/05/20
- Yatra terminates merger agreement with Ebix, files litigation
- 01/24/20
- BlueCrest Capital reports 5.1% passive stake in Yatra
- 06/08/20
- Thor Industries provides update amid COVID-19 pandemic
- 06/08/20
- Thor Industries says North America market indicators are increasingly positive
- 05/29/20
- Thor Industries announces operational update with start of RV travel season
- 05/26/20
- Recreational vehicle stocks spike amid safe travel concerns, outdoor season
- 04/30/20
- REV Group announces production update amid COVID-19
- 04/27/20
- Total RV shipments down 20.3% in March, RV Industry Association says
- 04/09/20
- REV Group to suspend dividend starting in Q2
- 03/26/20
- REV Group suspends RV production at Indiana and California facilities
- 06/08/20
- PG&E to pursue $5.75B offerings of stock, equity units
- 06/08/20
- PG&E to pursue $5.75B offerings of stock, equity units
- 06/08/20
- PG&E announces $3.25B common stock investment from multiple investors
- 06/08/20
- PG&E announces $3.25B common stock investment from multiple investors
MGTA Magenta Therapeutics - 06/05/20
- Magenta Therapeutics presents preclinical CD45-ADC data at EULAR meeting
- 05/06/20
- Magenta Therapeutics, Avrobio announce MGTA-117 collaboration agreement
- 04/16/20
- Magenta Therapeutics provides business operations update amid COVID-19 outbreak
- 04/16/20
- Magenta Therapeutics provides clinical programs update amid COVID-19 pandemic
- 06/03/20
- Kezar Life Sciences announces updated results from portion of MISSION trial
- 05/04/20
- Kezar Life Sciences appoints Noreen Henig, MD as Chief Medical Officer
- 04/09/20
- Kezar Life Sciences expects cash to fund company into 3Q22
- 04/09/20
- Kezar Life Sciences on track for IND application for KZR-261 in 1Q21
- 06/07/20
- Fly Intel: Top five weekend stock stories
- 06/05/20
- Filgotinib showed higher patient proportion with ACR20 response in PsA
- 06/05/20
- Efficacy of Gilead/Galapagos's Filgotinib supported in new phase 2 data
- 06/04/20
- Gilead, Galapagos announce Week 52 results from Phase 3 FINCH 1, FINCH 3 studies
- 06/01/20
- Fiat Chrysler appoints Paolo Carmassi as CEO of Comau
- 05/19/20
- EU passenger car registrations down 76.3% in April
- 05/18/20
- Fiat Chrysler says 12,000 U.S. workers back at U.S. manufacturing facilities
- 05/17/20
- FCA Italy working on activation of credit facility to support sector in Italy
- 06/05/20
- AstraZeneca says Calquence 'promising' in treating hospitalized COVID patients
- 06/04/20
- AstraZeneca reports 'steps towards broad and equitable access' to COVID vaccine
- 06/04/20
- AstraZeneca Accent Therapeutics announce novel cancer therapeutics collaboration
- 06/08/20 Jefferies
- Jefferies' Welford questions benefit to AstraZeneca of merger with Gilead
- 06/08/20 Bernstein
- Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
- 06/08/20 Jefferies
- Jefferies' Yee sees Gilead merger with AstraZeneca as unlikely
- 06/08/20 JPMorgan
- JPMorgan sees low proability of AstraZeneca, Gilead merger
MGTA Magenta Therapeutics - 06/08/20 Goldman Sachs
- Magenta Therapeutics upgraded to Buy from Neutral at Goldman Sachs
- 01/15/20 BTIG
- BTIG sees 'no real reason' for Magenta Therapeutics sell-off
- 12/06/19 BTIG
- Magenta Therapeutics initiated with a Buy at BTIG
- 12/06/19 Goldman Sachs
- Magenta Therapeutics assumed with a Neutral at Goldman Sachs
- 03/24/20 UBS
- Tesla and BMW upgraded, Ford downgraded at UBS
- 03/11/20 Morgan Stanley
- Morgan Stanley cuts estimates for GM, Ford and FCA on coronavirus 'demand shock'
- 12/18/19 Evercore ISI
- Evercore ISI upgrades Fiat Chrysler to Outperform after Peugeot deal formalized
- 12/18/19 Evercore ISI
- Fiat Chrysler upgraded to Outperform from In Line at Evercore ISI
- 06/01/20 Monness Crespi
- Camping World price target raised to $24 from $18 at Monness Crespi
- 04/17/20 Wolfe Research
- Thor Industries initiated with an Outperform at Wolfe Research
- 04/14/20 KeyBanc
- Thor Industries price target lowered to $62 from $69 at KeyBanc
- 04/08/20 Northcoast
- Thor Industries, Camping World downgraded at Northcoast after RV industry checks
- 03/25/20 Wells Fargo
- REV Group price target lowered to $4 from $10 at Wells Fargo
- 01/14/20 Wells Fargo
- REV Group downgraded to Underweight from Equal Weight at Wells Fargo
- 12/16/19 Morgan Stanley
- REV Group cut to Underweight on labor issues, weak RV market at Morgan Stanley
- 12/16/19 Morgan Stanley
- REV Group downgraded to Underweight from Equal Weight at Morgan Stanley
- 06/05/20 BofA
- PG&E resumed with a Buy at BofA
- 05/15/20 Barclays
- Barclays upgrades Utilities sector along with PG&E and two others
- 05/15/20 Barclays
- PG&E upgraded to Overweight from Equal Weight at Barclays
- 05/06/20 Mizuho
- PG&E price target raised to $13.50 from $12.50 at Mizuho
- 11/13/19 BMO Capital
- Ebix price target lowered to $46 from $50 at BMO Capital
- 06/04/20 H.C. Wainwright
- Kezar Life Sciences price target raised to $12 from $9 at H.C. Wainwright
- 05/05/20 H.C. Wainwright
- Kezar Life Sciences price target lowered to $9 from $15 at H.C. Wainwright
- 07/29/19 H.C. Wainwright
- Kezar Life Sciences initiated with a Buy at H.C. Wainwright
- 06/08/20
- Thor Industries reports Q3 EPS 43c, consensus (26c)
- 03/09/20
- Thor Industries reports Q2 EPS 52c, consensus 70c
- 12/09/19
- Thor Industries reports Q1 EPS 92c, consensus $1.23
- 06/08/20
- REV Group reports Q2 adj. EPS (9c), consensus (16c)
- 03/26/20
- REV Group withdraws FY20 guidance
- 03/04/20
- REV Group still sees FY20 revenue $2.6B-$2.8B, consensus $2.49B
- 03/04/20
- REV Group reports Q1 adjusted EPS (4c), consensus (5c)
- 05/01/20
- PG&E not providing FY20 guidance
- 05/01/20
- PG&E reports Q1 core EPS 89c, consensus $1.02
- 02/18/20
- PG&E reports Q4 adj. EPS 68, consensus 67c
MGTA Magenta Therapeutics - 05/07/20
- Magenta Therapeutics reports Q1 EPS (51c), consensus (60c)
- 03/03/20
- Magenta Therapeutics reports Q4 adj. EPS (59c), consensus (59c)
- 05/07/20
- Kezar Life Sciences reports Q1 EPS (30c), consensus (38c)
- 03/12/20
- Kezar Life Sciences reports Q4 EPS (50c), consensus (54c)
- 05/10/20
- Fly Intel: Top five weekend stock stories
- 04/30/20
- Gilead says there is 'significant' uncertainty about COVID-19 impact
- 04/30/20
- Gilead says Q1 product sales included $200M from pandemic trends
- 04/30/20
- Gilead reports Q1 adjusted EPS $1.68, consensus $1.57
- 05/05/20
- Fiat Chrysler reports Q1 EPS (EUR0.30) vs. EUR0.36 last year
- 02/06/20
- Fiat Chrysler backs FY20 adjusted EPS view of greater than or more than EUR2.80
- 02/06/20
- Fiat Chrysler reports FY19 adjusted EPS EUR2.73 vs. EUR3.00 last year
- 12/18/19
- Fiat Chrysler to distribute EUR 5.5B special dividend to holders
- 02/14/20
- AstraZeneca sees FY20 core EPS to increase by mid- to high-teens percentage
- 02/14/20
- AstraZeneca reports Q4 core EPS 89c, consensus 98c
- 01/08/20
- Veracyte announces biopharmaceutical collaboration with Acerta Pharma
- 06/05/20
- PG&E jumps after Bloomberg says $11B debt deal coming to end bankruptcy
- 06/05/20
- PG&E readies 11B debt-financing package for bankruptcy exit, Bloomberg says
- 06/05/20
- PG&E facing last-minute challenge over bankruptcy voting process, WSJ says
- 05/27/20
- CPUC looks poised to approve PG&E reorganization plan, CTFN says
- 06/07/20
- AstraZeneca approaches Gilead about potential merger, Bloomberg says
- 06/02/20
- Emergency use of Gilead's remdesivir approved in India, Reuters reports
- 05/26/20
- Britain to provide remdesivir to certain COVID-19 patients, Reuters reports
- 05/25/20
- NIH says Gilead drug works best in COVID patients on oxygen, Reuters reports
- 06/08/20
- Fiat Chrysler-PSA merger faces EU antitrust concerns, Reuters reports
- 05/26/20
- Fiat Chrysler begins restart of Mexico auto plants, Reuters reports
- 05/25/20
- Intesa to give preliminary green light to state-backed loan for FCA,Reuters says
- 05/21/20
- FCA says Brazil car sales dropping 70%-75% so far this month, Reuters says
- 06/05/20
- AstraZeneca cancer drug shows signs of helping in severe COVID-19, Reuters says
- 06/05/20
- AstraZeneca's Calquence shows signs of helping COVID-19 patients, Reuters says
- 06/03/20
- Novavax sinks after White House omits as COVID vaccine finalist
- 03/23/20
- Fly Intel: After-Hours Movers
- 12/09/19
- Fly Intel: Wall Street's top stories for Monday
- 12/09/19
- Fly Intel: Wall Street's top stories at midday
- 05/29/20
- Fly Intel: Pre-market Movers
- 05/04/20
- Fly Intel: Pre-market Movers
- 03/23/20
- Fly Intel: Pre-market Movers
- 03/17/20
- Fly Intel: Pre-market Movers
- 06/04/20
- Fly Intel: Pre-market Movers
- 06/03/20
- Fly Intel: After-Hours Movers
- 02/10/20
- Fly Insider: Kezar, Grocery Outlet among weeks's notable insider trades
- 06/03/20
- Gilead, Zoom Video upgrades among today's top calls on Wall Street
- 06/01/20
- Fly Intel: Wall Street's top stories for Monday
- 06/01/20
- Fly Intel: Wall Street's top stories at midday
- 05/27/20
- Fly Intel: Pre-market Movers
- 05/13/20
- Fly Intel: After-Hours Movers
- 04/27/20
- Fly Intel: Pre-market Movers
- 04/04/20
- Week in Review: How Trump's policies moved stocks
- 04/02/20
- Fly Intel: Wall Street's top stories for Thursday
- 06/06/20
- Week in Review: How Trump's policies moved stocks
- 06/05/20
- Fly Intel: Wall Street's top stories for Friday
- 06/04/20
- Inovio, Novavax analysts undeterred by White House vaccine snub
- 06/03/20
- Fly Intel: Wall Street's top stories for Wednesday
- 12/18/19
- REV Group options imply 28.1% move in share price post-earnings
- 06/05/20
- PG&E call volume above normal and directionally bullish
- 05/29/20
- Unusually active option classes on open May 29th
- 05/05/20
- PG&E call volume above normal and directionally bullish
- 05/04/20
- Early notable gainers among liquid option names on May 4th
- 05/28/20
- Thirteen new option listings and four option delistings on May 28th
- 06/04/20
- Gilead call volume above normal and directionally bullish
- 04/30/20
- Notable open interest changes for April 30th
- 04/29/20
- Unusually active option classes on open April 29th
- 04/24/20
- Notable open interest changes for April 24th
- 05/14/20
- Unusually active option classes on open May 14th
- 03/09/20
- Fiat Chrysler put volume heavy and directionally bearish
- 03/05/20
- Largest borrow rate increases among liquid names
- 01/14/20
- Unusually active option classes on open January 14th
- 05/28/20
- Unusually active option classes on open May 28th
- 05/27/20
- AstraZeneca call volume above normal and directionally bullish
- 05/22/20
- Unusually active option classes on open May 22nd
|